1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > In Vitro Diagnostics Market by Product Technology by Application - Forecast to 2020

In vitro diagnostics (IVD) testing is an indispensable tool in the modern medical practice. IVD tests are conducted to diagnose a number of diseases. With the evolution of biotechnology, there has been a drastic change in the type of tests conducted for diagnosing various diseases; this helped physicians across the globe to diagnose and treat diseases promptly and effectively. The increasing usage of self-testing kits is the most important trend witnessed recently in the IVD industry is that of

The global IVD market is expected to reach USD 75.1 billion by 2020, growing at a CAGR of 5.8% during the forecast period (2015 to 2020). The market is mainly driven by the rising incidences of chronic lifestyle diseases in emerging economies, growing aging population, and rising adoption of point-of-care testing and personalized medicine.

In this report, the market is segmented by product, technology, application, end user, and region. The IVD market, by product, is segmented into reagents and kits, instruments, services, and data management system/software. In 2014, the reagents and kits segment accounted for the largest share of approximately 79.3% of the IVD product market, and is expected to grow at a CAGR of 6.4% during the forecast period. Growth in this segment is mainly attributed to the increasing demand for diagnostic tests and launch of new reliable, specific, and faster detection reagents.

On the basis of applications, the IVD market is segmented into diabetes, infectious diseases, oncology, cardiology, HIV/AIDS, autoimmune diseases, drug testing, nephrology, and other applications. The oncology segment is expected to grow at the highest CAGR of 9.6% during the forecast period, owing to the increasing number of cancer patients across the world.

In 2014, North America commanded the largest share of the global IVD market, followed by Europe, Asia-Pacific, and the RoW. North America accounted for the largest share of 42.5% of global IVD market in 2014. The U.S. is a prime market due to the availability of government funds, expansion of molecular diagnostics for genetic disorders and cancer screening, and easy access to IVD tests through diagnostic service providers and major leading companies headquartered in the U.S. On the other hand, Asia-Pacific is the fastest-growing region in the global IVD market, mainly driven by the increasing demand for IVD tests from large patient population, increased spending capabilities of consumers on healthcare, improving healthcare infrastructure in the region, and increasing investment by leading players and respective government agencies in the region.

The major players in the IVD market are Roche Diagnostics Limited (Switzerland), Abbott Laboratories, Inc. (U.S.), Becton, Dickson and Company (U.S.), Ortho-Clinical Diagnostics (U.S.), Johnson and Johnson (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Siemens Healthcare (Germany), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation (Japan), and bioMérieux (France).

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping greater market shares.

This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by top players in the IVD market. The report analyzes the IVD market by product, technology, end user, and application across all regions
- Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and new product launches in the IVD market
- Market Development: Comprehensive information on the lucrative emerging markets by product, technology, end user, application, and region
- Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the IVD market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of leading players in the IVD market

Table Of Contents

In Vitro Diagnostics Market by Product Technology by Application - Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 22
1.3.2 YEARS CONSIDERED FOR THE STUDY 23
1.4 CURRENCY 23
1.5 LIMITATIONS 23
1.6 STAKEHOLDERS 24
2 RESEARCH METHODOLOGY 25
2.1 RESEARCH DATA 25
2.1.1 SECONDARY DATA 25
2.1.1.1 Key data from secondary sources 26
2.1.2 PRIMARY DATA 26
2.1.2.1 Key data from primary sources 27
2.1.2.2 Key industry insights 28
2.1.2.3 Breakdown of primary interviews 28
2.2 MARKET SIZE ESTIMATION 29
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 31
2.4 MARKET SHARE ESTIMATION 32
2.5 ASSUMPTIONS FOR THE STUDY 32
3 EXECUTIVE SUMMARY 33
4 PREMIUM INSIGHTS 38
4.1 GROWTH POTENTIAL OF THE IVD MARKET 38
4.2 ASIA-PACIFIC: IVD MARKET 39
4.3 IVD MARKET: GEOGRAPHIC SNAPSHOT 40
4.4 GEOGRAPHIC MIX: IVD MARKET, BY TECHNOLOGY 41
4.5 IVD MARKET: EMERGING VS. DEVELOPED MARKETS 42
5 MARKET OVERVIEW 43
5.1 INTRODUCTION 44
5.2 MARKET SEGMENTATION 44
5.2.1 IN VITRO DIAGNOSTICS MARKET, BY PRODUCT 44
5.2.2 IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 45
5.2.3 IN VITRO DIAGNOSTICS MARKET, BY APPLICATION 45
5.2.4 IN VITRO DIAGNOSTICS MARKET, BY END USER 46
5.3 MARKET DYNAMICS 46
5.3.1 DRIVERS 47
5.3.1.1 Rising incidence of chronic lifestyle diseases across the globe 47
5.3.1.2 Rapid growth in the geriatric population 48
5.3.1.3 Increasing adoption of point-of-care (POC) testing 48
5.3.1.4 Growing awareness of personalized medicine 49
5.3.2 RESTRAINTS 49
5.3.2.1 Inadequate reimbursement 49
5.3.2.2 Implementation of excise duty by the U.S. government 50
5.3.3 OPPORTUNITIES 50
5.3.3.1 New range of condition-specific markers and tests with advances in genomics and proteomics 50
5.3.3.2 Emerging economies with increasing investments 50
5.3.4 CHALLENGES 51
5.3.4.1 Stringent regulatory framework 51
6 INDUSTRY INSIGHTS 53
6.1 INTRODUCTION 53
6.2 ACQUISITIONS FROM LEADING PLAYERS RESULTING IN CONSOLIDATION OF THE IVD MARKET 53
6.3 PORTER'S FIVE FORCE ANALYSIS 54
6.3.1 THREAT OF NEW ENTRANTS 54
6.3.2 THREAT OF SUBSTITUTES 54
6.3.3 BARGAINING POWER OF SUPPLIERS 55
6.3.4 BARGAINING POWER OF BUYERS 55
6.3.5 INTENSITY OF COMPETITIVE RIVALRY 55
6.4 REGULATORY OVERVIEW 56
6.4.1 NORTH AMERICA 56
6.4.1.1 U.S. 56
6.4.1.2 Canada 56
6.4.2 EUROPE 57
6.4.3 ASIA-PACIFIC 58
6.4.3.1 Japan 58
6.4.3.2 China 59
6.4.3.3 India 59
6.4.3.4 Australia 60
7 GLOBAL IVD MARKET, BY PRODUCT and SERVICE 61
7.1 INTRODUCTION 62
7.2 REAGENTS and KITS 63
7.3 INSTRUMENTS 65
7.4 DATA MANAGEMENT SOFTWARE 67
7.5 SERVICES 68
8 GLOBAL IVD MARKET, BY TECHNOLOGY 70
8.1 INTRODUCTION 71
8.2 CLINICAL CHEMISTRY 72
8.2.1 BASIC METABOLIC PANELS 74
8.2.2 ELECTROLYTE PANELS 75
8.2.3 LIVER PANELS 76
8.2.4 LIPID PROFILES 77
8.2.5 RENAL PROFILES 78
8.2.6 THYROID FUNCTION PANELS 79
8.2.7 SPECIALTY CHEMICAL TESTS 80
8.3 IMMUNOCHEMISTRY/IMMUNOASSAYS 81
8.3.1 ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) 83
8.3.1.1 Chemiluminescence Immunoassays (CLIAs) 85
8.3.1.2 Fluorescence Immunoassays (FIA) 87
8.3.1.3 Colorimetric Immunoassays (CI) 88
8.3.2 RADIOIMMUNOASSAYS (RIA) 89
8.3.3 RAPID TESTS 91
8.3.4 WESTERN BLOT 92
8.3.5 ENZYME LINKED IMMUNOSPOT ASSAY (ELISPOT) 93
8.4 HEMATOLOGY 94
8.5 COAGULATION AND HEMOSTASIS 95
8.6 MICROBIOLOGY 97
8.7 MOLECULAR DIAGNOSTICS (MDX) 98
8.7.1 POLYMERASE CHAIN REACTION (PCR) 99
8.7.2 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT) 100
8.7.3 MICROARRAYS 101
8.7.4 HYBRIDIZATION 103
8.7.5 DNA SEQUENCING and NEXT-GENERATION SEQUENCING 104
8.7.6 OTHER MDX TECHNOLOGIES 105
8.8 OTHER IVD TECHNOLOGIES 107
9 IN VITRO DIAGNOSTICS MARKET, BY APPLICATION 108
9.1 INTRODUCTION 109
9.2 DIABETES 110
9.3 INFECTIOUS DISEASES 112
9.4 ONCOLOGY/CANCER 113
9.5 CARDIOLOGY 115
9.6 NEPHROLOGY 116
9.7 AUTOIMMUNE DISEASES 117
9.8 DRUG TESTING 118
9.9 HIV/AIDS 120
9.10 OTHER APPLICATIONS 121
10 GLOBAL IVD MARKET, BY END USER 122
10.1 INTRODUCTION 123
10.2 LABORATORIES 124
10.3 HOSPITALS 125
10.4 ACADEMIC INSTITUTES 126
10.5 POINT-OF-CARE TESTING 127
10.6 PATIENT SELF-TESTING 129
10.7 OTHERS 130
11 GEOGRAPHIC ANALYSIS 131
11.1 INTRODUCTION 132
11.2 NORTH AMERICA 135
11.2.1 U.S. 139
11.2.2 CANADA 141
11.3 EUROPE 143
11.3.1 GERMANY 148
11.3.2 FRANCE 151
11.3.3 U.K. 153
11.3.4 ITALY 155
11.3.5 SPAIN 157
11.3.6 RUSSIA 159
11.3.7 REST OF EUROPE (ROE) 161
11.4 ASIA-PACIFIC (APAC) 164
11.4.1 JAPAN 166
11.4.2 CHINA 168
11.4.3 INDIA 171
11.4.4 REST OF ASIA-PACIFIC (ROAPAC) 173
11.5 REST OF THE WORLD (ROW) 175
11.5.1 LATIN AMERICA 178
11.5.1.1 Brazil 180
11.5.1.2 Mexico 183
11.5.1.3 Rest of Latin America (RoLA) 185
11.5.2 MIDDLE EAST AND AFRICA 187
12 COMPETITIVE LANDSCAPE 190
12.1 OVERVIEW 190
12.2 MARKET SHARE ANALYSIS 191
12.3 COMPETITIVE SITUATION AND TRENDS 192
12.4 NEW PRODUCT LAUNCHES 193
12.5 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 194
12.6 MERGERS AND ACQUISITIONS 195
12.7 EXPANSIONS 196
13 COMPANY PROFILES 197
13.1 ABBOTT LABORATORIES, INC. 198
13.2 DANAHER CORPORATION 202
13.3 JOHNSON AND JOHNSON 208
13.4 ROCHE DIAGNOSTICS 211
13.5 SIEMENS HEALTHCARE 216
13.6 BECTON, DICKINSON AND COMPANY 222
13.7 BIOMÉRIEUX 227
13.8 BIO-RAD LABORATORIES, INC. 232
13.9 ORTHO CLINICAL DIAGNOSTICS, INC. 237
13.10 SYSMEX CORPORATION 239
13.11 THERMO FISHER SCIENTIFIC, INC. 244
*Details On Financials, Products and Services, Key Strategy, and Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
14 APPENDIX 249
14.1 INSIGHTS OF INDUSTRY EXPERTS 249
14.2 DISCUSSION GUIDE 250
14.3 OTHER DEVELOPMENTS, 2012-2015 254
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 268
14.5 AVAILABLE CUSTOMIZATIONS 270
14.6 RELATED REPORTS 271


LIST OF TABLES

TABLE 1 INCREASED INCIDENCE OF CHRONIC LIFESTYLE DISEASES AND RAPID GROWTH IN GERIATRIC POPULATION WILL DRIVE THE MARKET GROWTH 49
TABLE 2 LACK OF REIMBURSEMENT AND IMPLEMENTATION OF EXCISE DUTY TO RESTRAIN THE MARKET GROWTH 50
TABLE 3 EMERGING ECONOMIES WITH INCREASING INVESTMENTS OFFER SIGNIFICANT OPPORTUNITIES FOR MARKET GROWTH 51
TABLE 4 STRINGENT REGULATIONS CONTINUE TO BE A KEY CHALLENGE FOR THE IVD MARKET 52
TABLE 5 GLOBAL IVD MARKET, BY PRODUCT and SERVICE, 2013-2020 (USD MILLION) 63
TABLE 6 GLOBAL IVD REAGENTS and KITS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 64
TABLE 7 GLOBAL IVD REAGENTS and KITS MARKET SIZE, BY TECHNOLOGY,
2013-2020 (USD MILLION) 64
TABLE 8 GLOBAL IVD INSTRUMENTS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 66
TABLE 9 GLOBAL IVD INSTRUMENTS MARKET SIZE, BY TECHNOLOGY,
2013-2020 (USD MILLION) 66
TABLE 10 GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 67
TABLE 11 GLOBAL IVD DATA MANAGEMENT SOFTWARE MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 68
TABLE 12 GLOBAL IVD SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 69
TABLE 13 GLOBAL IVD SERVICES MARKET SIZE, BY TECHNOLOGY,
2013-2020 (USD MILLION) 69
TABLE 14 GLOBAL IVD MARKET, BY TECHNOLOGY, 2013 - 2020 (USD MILLION) 71
TABLE 15 GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 73
TABLE 16 GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY TEST, 2013-2020 (USD MILLION) 73
TABLE 17 GLOBAL BASIC METABOLIC PANELS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 74
TABLE 18 GLOBAL ELECTROLYTE PANELS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 75
TABLE 19 GLOBAL LIVER PANELS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 76
TABLE 20 GLOBAL LIPID PROFILES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 77
TABLE 21 GLOBAL RENAL PROFILES MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 78
TABLE 22 GLOBAL THYROID FUNCTION PANELS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 79
TABLE 23 GLOBAL SPECIALTY CHEMICAL TESTS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 80
TABLE 24 GLOBAL IMMUNOASSAY/IMMUNOCHEMISTRY MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 81
TABLE 25 GLOBAL IMMUNOASSAY/IMMUNOCHEMISTRY MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 82
TABLE 26 GLOBAL ELISA MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 84
TABLE 27 GLOBAL ELISA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 84
TABLE 28 GLOBAL CHEMILUMINESCENCE IMMUNOASSAYS (CLIA) MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 86
TABLE 29 GLOBAL FLUORESCENCE IMMUNOASSAYS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 88
TABLE 30 GLOBAL COLORIMETRIC IMMUNOASSAYS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 89
TABLE 31 GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 90
TABLE 32 GLOBAL RAPID TESTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 91
TABLE 33 GLOBAL WESTERN BLOT MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 92
TABLE 34 GLOBAL ELISPOT MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 93
TABLE 35 GLOBAL HEMATOLOGY MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 94
TABLE 36 GLOBAL COAGULATION and HEMOSTASIS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 96
TABLE 37 GLOBAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 97
TABLE 38 GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 98
TABLE 39 GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 (USD MILLION) 99
TABLE 40 GLOBAL PCR MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY,
2013-2020 (USD MILLION) 100
TABLE 41 GLOBAL INAAT MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2013-2020 (USD MILLION) 101
TABLE 42 GLOBAL MICROARRAYS MARKET SIZE FOR MOLECULAR DIAGNOSTICS,
BY COUNTRY, 2013-2020 (USD MILLION) 102
TABLE 43 GLOBAL HYBRIDIZATION MARKET SIZE FOR MOLECULAR DIAGNOSTICS,
BY COUNTRY, 2013-2020 (USD MILLION) 103
TABLE 44 GLOBAL DNA SEQUENCING and NGS MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2013-2020 (USD MILLION) 105
TABLE 45 GLOBAL OTHER MDX TECHNOLOGIES MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2013-2020 (USD MILLION) 106
TABLE 46 GLOBAL OTHER IVD TECHNOLOGIES MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 107
TABLE 47 GLOBAL IVD MARKET SIZE, BY APPLICATION, 2013 - 2020 (USD MILLION) 110
TABLE 48 GLOBAL DIABETIC PATIENT POPULATION (2014) 110
TABLE 49 GLOBAL IVD MARKET SIZE FOR DIABETES, BY COUNTRY,
2013-2020 (USD MILLION) 111
TABLE 50 GLOBAL IVD MARKET SIZE FOR INFECTIOUS DISEASES, BY COUNTRY,
2013-2020 (USD MILLION) 113
TABLE 51 GLOBAL IVD MARKET SIZE FOR ONCOLOGY, BY COUNTRY,
2013-2020 (USD MILLION) 114
TABLE 52 GLOBAL IVD MARKET SIZE FOR CARDIOLOGY, BY COUNTRY,
2013-2020 (USD MILLION) 115
TABLE 53 GLOBAL IVD MARKET SIZE FOR NEPHROLOGY, BY COUNTRY,
2013-2020 (USD MILLION) 116
TABLE 54 GLOBAL IVD MARKET SIZE FOR AUTOIMMUNE DISEASES, BY COUNTRY,
2013-2020 (USD MILLION) 117
TABLE 55 GLOBAL IVD MARKET SIZE FOR DRUG TESTING, BY COUNTRY,
2013-2020 (USD MILLION) 119
TABLE 56 GLOBAL IVD MARKET SIZE FOR HIV/AIDS, BY COUNTRY, 2013-2020 (USD MILLION) 120
TABLE 57 GLOBAL IVD MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY,
2013-2020 (USD MILLION) 121
TABLE 58 GLOBAL IVD MARKET, BY END USER, 2013-2020 (USD MILLION) 123
TABLE 59 GLOBAL IVD MARKET SIZE FOR LABORATORIES, BY COUNTRY,
2013-2020 (USD MILLION) 124
TABLE 60 GLOBAL IVD MARKET SIZE FOR HOSPITALS, BY COUNTRY,
2013-2020 (USD MILLION) 125
TABLE 61 GLOBAL IVD MARKET SIZE FOR ACADEMIC INSTITUTES, BY COUNTRY,
2013-2020 (USD MILLION) 126
TABLE 62 GLOBAL IVD MARKET SIZE FOR POC TESTING, BY COUNTRY,
2013-2020 (USD MILLION) 128
TABLE 63 GLOBAL IVD MARKET SIZE FOR PATIENT SELF-TESTING, BY COUNTRY,
2013-2020 (USD MILLION) 129
TABLE 64 GLOBAL IVD MARKET SIZE FOR OTHER END USERS, BY COUNTRY,
2013-2020 (USD MILLION) 130
TABLE 65 GLOBAL IVD MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 132
TABLE 66 GLOBAL IVD MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 133
TABLE 67 NORTH AMERICA: IVD MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 135
TABLE 68 NORTH AMERICA: IVD MARKET SIZE, BY PRODUCT and SERVICES
2013-2020 (USD MILLION) 137
TABLE 69 NORTH AMERICA: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 137
TABLE 70 NORTH AMERICA: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 138
TABLE 71 NORTH AMERICA: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 138
TABLE 72 U.S.: IVD MARKET SIZE, BY PRODUCT and SERVICES, 2013-2020 (USD MILLION) 139
TABLE 73 U.S.: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 140
TABLE 74 U.S.: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 140
TABLE 75 U.S.: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 141
TABLE 76 CANADA: IVD MARKET SIZE, BY PRODUCT and SERVICES,
2013-2020 (USD MILLION) 141
TABLE 77 CANADA: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 142
TABLE 78 CANADA: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 142
TABLE 79 CANADA: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 143
TABLE 80 EUROPE: IVD MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 144
TABLE 81 EUROPE: IVD MARKET SIZE, BY PRODUCT and SERVICES,
2013-2020 (USD MILLION) 146
TABLE 82 EUROPE: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 146
TABLE 83 EUROPE: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 147
TABLE 84 EUROPE: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 147
TABLE 85 GERMANY: IVD MARKET SIZE, BY PRODUCT and SERVICES,
2013-2020 (USD MILLION) 149
TABLE 86 GERMANY: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 149
TABLE 87 GERMANY: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 150
TABLE 88 GERMANY: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 150
TABLE 89 FRANCE: IVD MARKET SIZE, BY PRODUCT and SERVICES, 2013-2020 (USD MILLION) 151
TABLE 90 FRANCE: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 151
TABLE 91 FRANCE: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 152
TABLE 92 FRANCE: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 152
TABLE 93 U.K.: IVD MARKET SIZE, BY PRODUCT and SERVICES, 2013-2020 (USD MILLION) 153
TABLE 94 U.K.: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 153
TABLE 95 U.K.: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 154
TABLE 96 U.K.: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 154
TABLE 97 ITALY: IVD MARKET SIZE, BY PRODUCT and SERVICES, 2013-2020 (USD MILLION) 155
TABLE 98 ITALY: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 155
TABLE 99 ITALY: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 156
TABLE 100 ITALY: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 156
TABLE 101 SPAIN: IVD MARKET SIZE, BY PRODUCT and SERVICES, 2013-2020 (USD MILLION) 157
TABLE 102 SPAIN: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 157
TABLE 103 SPAIN: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 158
TABLE 104 SPAIN: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 158
TABLE 105 RUSSIA: IVD MARKET SIZE, BY PRODUCT and SERVICES, 2013-2020 (USD MILLION) 159
TABLE 106 RUSSIA: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 160
TABLE 107 RUSSIA: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 160
TABLE 108 RUSSIA: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 161
TABLE 109 ROE: IVD MARKET SIZE, BY PRODUCT and SERVICES, 2013-2020 (USD MILLION) 161
TABLE 110 ROE: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 162
TABLE 111 ROE: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 162
TABLE 112 ROE: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 163
TABLE 113 APAC: IVD MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 164
TABLE 114 APAC: IVD MARKET SIZE, BY PRODUCT and SERVICES, 2013-2020 (USD MILLION) 164
TABLE 115 APAC: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 165
TABLE 116 APAC: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 165
TABLE 117 APAC: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 166
TABLE 118 JAPAN: IVD MARKET SIZE, BY PRODUCT and SERVICES, 2013-2020 (USD MILLION) 166
TABLE 119 JAPAN: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 167
TABLE 120 JAPAN: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 167
TABLE 121 JAPAN: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 168
TABLE 122 CHINA: IVD MARKET SIZE, BY PRODUCT and SERVICES, 2013-2020 (USD MILLION) 169
TABLE 123 CHINA: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 169
TABLE 124 CHINA: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 170
TABLE 125 CHINA: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 170
TABLE 126 INDIA: IVD MARKET SIZE, BY PRODUCT and SERVICES, 2013-2020 (USD MILLION) 171
TABLE 127 INDIA: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 172
TABLE 128 INDIA: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 172
TABLE 129 INDIA: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 173
TABLE 130 ROAPAC: IVD MARKET SIZE, BY PRODUCT and SERVICES, 2013-2020 (USD MILLION) 173
TABLE 131 ROAPAC: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 174
TABLE 132 ROAPAC: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 174
TABLE 133 ROAPAC: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 175
TABLE 134 ROW: IVD MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 175
TABLE 135 ROW: IVD MARKET SIZE, BY PRODUCT and SERVICES, 2013-2020 (USD MILLION) 176
TABLE 136 ROW: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 176
TABLE 137 ROW: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 177
TABLE 138 ROW: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 177
TABLE 139 LATIN AMERICA: IVD MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 178
TABLE 140 LATIN AMERICA: IVD MARKET SIZE, BY PRODUCT and SERVICES,
2013-2020 (USD MILLION) 178
TABLE 141 LATIN AMERICA: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 179
TABLE 142 LATIN AMERICA: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 179
TABLE 143 LATIN AMERICA: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 180
TABLE 144 BRAZIL: IVD MARKET SIZE, BY PRODUCT and SERVICES, 2013-2020 (USD MILLION) 181
TABLE 145 BRAZIL: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 181
TABLE 146 BRAZIL: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 182
TABLE 147 BRAZIL: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 182
TABLE 148 MEXICO: IVD MARKET SIZE, BY PRODUCT and SERVICES, 2013-2020 (USD MILLION) 183
TABLE 149 MEXICO: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 183
TABLE 150 MEXICO: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 184
TABLE 151 MEXICO: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 184
TABLE 152 ROLA: IVD MARKET SIZE, BY PRODUCT and SERVICES, 2013-2020 (USD MILLION) 185
TABLE 153 ROLA: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 185
TABLE 154 ROLA: IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 186
TABLE 155 ROLA: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 186
TABLE 156 MIDDLE EAST AND AFRICA: IVD MARKET SIZE, BY PRODUCT and SERVICES,
2013-2020 (USD MILLION) 187
TABLE 157 MIDDLE EAST AND AFRICA: IVD MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 188
TABLE 158 MIDDLE EAST AND AFRICA: IVD MARKET SIZE, BY TECHNOLOGY,
2013-2020 (USD MILLION) 188
TABLE 159 MIDDLE EAST AND AFRICA: IVD MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 189
TABLE 160 NEW PRODUCT LAUNCHES, 2012-2015 193
TABLE 161 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012-2015 194
TABLE 162 MERGERS AND ACQUISITIONS, 2012-2015 195
TABLE 163 EXPANSIONS, 2012-2015 196



LIST OF FIGURES

FIGURE 1 GLOBAL IN VITRO DIAGNOSTICS MARKET 22
FIGURE 2 RESEARCH DESIGN 25
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 28
FIGURE 4 BOTTOM-UP APPROACH 29
FIGURE 5 TOP-DOWN APPROACH 30
FIGURE 6 DATA TRIANGULATION METHODOLOGY 31
FIGURE 7 GLOBAL IVD MARKET SIZE, BY PRODUCTS and SERVICES,
2015 VS. 2020 (USD MILLION) 34
FIGURE 8 GLOBAL IVD MARKET SIZE, BY APPLICATION, 2015 VS. 2020 (USD MILLION) 34
FIGURE 9 GLOBAL IVD MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION) 35
FIGURE 10 IVD MARKET: GEOGRAPHIC SNAPSHOT 36
FIGURE 11 CHINA AND INDIA TO DRIVE THE GROWTH OF THE IVD MARKET IN
ASIA-PACIFIC REGION 37
FIGURE 12 INCREASING INCIDENCE OF CHRONIC LIFESTYLE DISEASES IS DRIVING GROWTH IN THE IVD MARKET 38
FIGURE 13 REAGENTS and KITS TO ACCOUNT FOR THE LARGEST SHARE OF THE IVD MARKET IN NORTH AMERICA 39
FIGURE 14 U.S. TO COMMAND MORE THAN ONE-THIRD OF THE GLOBAL IVD MARKET 40
FIGURE 15 NORTH AMERICA TO DOMINATE THE MOLECULAR DIAGNOSTICS and MICROBIOLOGY MARKETS 41
FIGURE 16 EMERGING MARKETS ARE ESTIMATED TO GROW AT A HIGHER RATE DURING THE FORECAST PERIOD 42
FIGURE 17 IN VITRO DIAGNOSTICS MARKET SEGMENTATION, BY PRODUCT 44
FIGURE 18 IN VITRO DIAGNOSTICS MARKET SEGMENTATION, BY TECHNOLOGY 45
FIGURE 19 IN VITRO DIAGNOSTICS MARKET SEGMENTATION, BY APPLICATION 45
FIGURE 20 IN VITRO DIAGNOSTICS MARKET SEGMENTATION, BY END USER 46
FIGURE 21 IVD MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, and CHALLENGES 47
FIGURE 22 PORTER'S FIVE FORCE ANALYSIS 54
FIGURE 23 REGULATORY APPROVAL PROCESS IN CHINA 59
FIGURE 24 REGULATORY APPROVAL PROCESS IN INDIA 60
FIGURE 25 REAGENTS and KITS THE FASTEST GROWING SEGMENT OF THE IVD MARKET 62
FIGURE 26 MOLECULAR DIAGNOSTICS WILL GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD OF 2015-2020 71
FIGURE 27 ONCOLOGY IS THE FASTEST-GROWING SEGMENT OF THE IVD MARKET 109
FIGURE 28 GLOBAL IVD MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION) 123
FIGURE 29 NORTH AMERICA TO DOMINATE THE IVD MARKET 134
FIGURE 30 NORTH AMERICAN IVD MARKET OVERVIEW 136
FIGURE 31 EUROPEAN IVD MARKET OVERVIEW 145
FIGURE 32 PLAYERS MAJORLY ADOPTED THE STRATEGY OF NEW PRODUCT LAUNCHES FROM 2012 TO 2015 190
FIGURE 33 GLOBAL IN VITRO DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 191
FIGURE 34 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY 192
FIGURE 35 GEOGRAPHIC REVENUE MIX OF THE TOP 5 MARKET PLAYERS 197
FIGURE 36 COMPANY SNAPSHOT: ABBOTT LABORATORIES, INC. 198
FIGURE 37 COMPANY SNAPSHOT: DANAHER CORPORATION 202
FIGURE 38 COMPANY SNAPSHOT: JOHNSON AND JOHNSON 208
FIGURE 39 COMPANY SNAPSHOT: F. HOFFMANN-LA ROCHE LTD. 211
FIGURE 40 COMPANY SNAPSHOT: SIEMENS AG 216
FIGURE 41 COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY 222
FIGURE 42 COMPANY SNAPSHOT: BIOMÉRIEUX 227
FIGURE 43 COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. 232
FIGURE 44 COMPANY SNAPSHOT: SYSMEX CORPORATION 239
FIGURE 45 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC. 244

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 1,007-page report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, ...

Point of Care Diagnostics, BCC Research

Point of Care Diagnostics, BCC Research

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

Use this report to: - Review business opportunities in the thriving near-patient testing market. - Learn about the impact of chronic diseases, growing and aging populations. - Receive information about ...

2016 World In Vitro Diagnostic Instrumentation Review

2016 World In Vitro Diagnostic Instrumentation Review

  • $ 6500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com reviews operating characteristics and features of major automated and semi-automated high-, medium-, and low-volume/POC in vitro diagnostic systems within the ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.